Sysmex (OTCMKTS:SSMXY) Shares Gap Up - Here's What Happened

Key Points

• Sysmex Corporation shares gapped up prior to trading on Monday, opening at $13.30 after closing at $12.72, with a trading volume of 207 shares.
• Zacks Research has upgraded Sysmex from a "strong sell" rating to a "hold" rating, with analysts currently maintaining a consensus rating of "Hold" for the stock.
• In its latest earnings report, Sysmex missed earnings expectations, reporting $0.05 EPS against a consensus estimate of $0.12, with revenues of $717.09 million compared to the estimated $807.27 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s share price gapped up prior to trading on Monday . The stock had previously closed at $12.72, but opened at $13.30. Sysmex shares last traded at $13.30, with a volume of 207 shares trading hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Sysmex currently has a consensus rating of "Hold".

Sysmex Stock Performance

The firm has a market cap of $8.00 billion, a price-to-earnings ratio of 25.42 and a beta of 1.10. The stock has a 50 day moving average of $14.77 and a 200 day moving average of $16.81. The company has a quick ratio of 2.49, a current ratio of 3.37 and a debt-to-equity ratio of 0.12.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). The business had revenue of $717.09 million for the quarter, compared to analyst estimates of $807.27 million. Sysmex had a return on equity of 10.20% and a net margin of 9.35%. As a group, analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.